Market News & Trends
Boehringer Ingelheim Announces US Filing for Fixed-Dose Combination Drug
Boehringer Ingelheim recently announced that the US FDA accepted for review the NDA for the fixed-dose combination (FDC) of tiotropium and olodaterol delivered via the…
Global Market for DNA Vaccines to Reach $2.7 Billion
The vaccine industry is rapidly changing from a mostly empirical approach to a rational design approach. Rapid developments in molecular biology, DNA synthesis, and immunobiology…
3M Celebrates 25th Anniversary of Breath-Actuated Inaher
It’s been happening about once every 6.6 seconds for the past 25 years, and you probably didn’t even realize it. Is it a baby being…
3M DDS Announces Collaboration With Presspart Group
ST. PAUL, Minn. – August 13, 2014 – 3M Drug Delivery Systems Division recently announced a new collaborative agreement with Presspart Group (a division of…
ADHD Treatment Market Value to Reach $9.9 Billion
The Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market value will rise from $6.9 billion in 2013 to $9.9 billion by 2020, with broadening diagnostic criteria a…
Global Market for DNA Vaccines to Reach $2.7 Billion
The vaccine industry is rapidly changing from a mostly empirical approach to a rational design approach. Rapid developments in molecular biology, DNA synthesis, and immunobiology…
Allergan Acquires LiRIS Program From TARIS Biomedical
Allergan Inc. and TARIS Holdings LLC recently announced that Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical’s lead program, LiRIS, which…
3M DDS Announces Collaboration With Presspart Group
ST. PAUL, Minn. – August 13, 2014 – 3M Drug Delivery Systems Division recently announced a new collaborative agreement with Presspart Group (a division of…
Baxter Biologics Facility In Asia, Announces Expansion Plans
Baxter International Inc. recently announced the formal opening of its first advanced recombinant biologic facility in Singapore, and expansion plans for a new recombinant protein…
Biotech Forward Pharma Files for $200-Million IPO
Forward Pharma A/S, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis, recently announced it has filed…
Coherus’ Biosimilar Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
Coherus BioSciences, Inc. recently announced that CHS-1420, its proposed biosimilar of adalimumab (Humira), met the primary endpoint in a pivotal clinical pharmacokinetic (PK) similarity study…
Seventh Sense Biosystems Closes $16-Million Financing
Seventh Sense Biosystems, Inc. (7SBio), the pioneering developer of virtually painless blood collection and diagnostic platforms, recently announced a $16-million Series B financing from a…
Pharmacogenetic Testing Company Launches Robust Drug Testing Program
Pinnacle Laboratory Services has successfully launched one of the most comprehensive Pharmacogenetic programs available on the market. Pinnacle Laboratory Services specializes in Pharmacogenetic testing with…
Optibrium Launches New Software for Compound Data Visualization
Optibrium recently announced the launch of Sentira, a new desktop application that provides dynamic data visualization and analysis of compound data. Applicable across all fields…
Ashland Commits to Major Capacity Expansion to Meet Customer Demand
Ashland Specialty Ingredients, a commercial unit of Ashland Inc. recently announced plans to significantly expand production capacity of its Klucel hydroxypropylcellulose (HPC) product line in…
Charleston Laboratories & Daiichi Sankyo Announce Major Collaboration
Charleston Laboratories, Inc., through its wholly owned subsidiary LOCL Pharma, Inc., and Daiichi Sankyo recently announced the parties have entered into a strategic collaboration for…
Sanofi & MannKind Announce Global Licensing Agreement
Sanofi and MannKind Corporation recently announced they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder,…
Immune Response BioPharma to Develop In-House Sales Force for Blockbuster Vaccine
New Jersey-based Immune Response BioPharma, Inc. recently announced its plans to create an in-house sales force for Remune, its HIV vaccine. Remune is a therapeutic…
Mexico’s Healthcare Market Value to Reach Almost $28 Billion by 2020, says GlobalData
LONDON, UK (GlobalData), 7 August 2014 - Mexico’s pharmaceutical and medical devices industries will be worth approximately $22.5 billion and $5.4 billion by 2020, respectively,…
